African programme for Onchoceriasis control: ophthalmological findings in Bushenyi, Uganda.

BACKGROUND: The overall prevalence of blindness from Onchoceriasis in Bushenyi is relatively low, most of which is to be found in the elderly. Onchoceriasis is a major health problem in Africa. The Community-Directed treatment with invermectin is a control strategy to address the problem, but baseline data are generally lacking in several countries. OBJECTIVE: To describe baseline ophthalmological data in order to assess the impact of Community-Directed with Ivermectin (CDTI) in Uganda. METHODS: The study site was in Bushenyi, Western Uganda. In a cross-sectional study, 367 persons aged 10 years or older from seven selected villages received eye examination using a standardised protocol and Wu-Jones Motion Sensitivity Testing (MSST). Besides MSST, other information sought included visual acuity, slit lamp examination, testicular opacities and intraocular presence. RESULTS: Of the 367 subjects, 219(57.2%) were males. Subjects less than 25 years of age were 104(28.3). The prevalence of blindness were 1.9% while 4.1% was visually impaired by acuity criteria alone. A further 9.1% had moderate visual field loss while 2.8% had severe field loss. There was no case of anterior chamber microfilaria but dead microfilariae were seen in two cases. Punctate keratitis was present in 1.8% with sclerosing keratitis was twice as common at 3.8%. Optic atrophy was also relatively common at 12.4%, while chorioretinitis was present in 3.3%. CONCLUSION: There was an apparent paucity of acute onchocerciasis-related lesions but a significant presence of irreversible onchocerciasis-related lesions. The most significant problem requiring intervention would appear to be cataract.

APOC impact assessment studies: baseline ophthalmological findings in Morogoro, Tanzania.

The goal of the African Programme for Onchocerciasis Control (APOC) is to eliminate Onchocerciasis as a disease of public Health significance and an important constraint to socio-economic development in the 19 none OCP (Onchocerciasis Control Project) countries covered through Community-Directed Treatment with Ivermectin, CDTI. In 1998, impact assessment studies were carried out in Morogoro, Tanzania during which baseline ophthalmological parameters were established. The hypothesis being tested is that CDTI will prevent or delay progression of onchocercal eye lesions and blindness. A total of 425 subjects aged 10 years or more from 14 villages within Bwakira district ofMorogoro region in Tanzania were examined for Snellen visual acuity, ocular microfilaria, lens opacities, uveitis and posterior segment disease especially chorioretinitis and optic nerve disease. Motion Sensitivity Screening Test (MSST) was carried out as well. Microfilaria was present in the anterior chamber of nearly half (49.2%) of all subjects examined. Prevalence of blindness was extremely high at 15.2%. Onchocercal lesions were responsible for blindness in 41.5% of these, followed by cataracts (27.7%), glaucoma (10.8%) and trachoma (6.2%). The main pathway to onchocercal blindness in this population was anterior uveitis with or without secondary cataracts. There is an urgent need to get CDTI underway and institute other horizontal primary eye care measures, especially cataract backlog reduction, in order to reduce the excessive burden of avoidable blindness in this community.